Literature DB >> 16133488

Isobolographic characterisation of interactions among selected newer antiepileptic drugs in the mouse pentylenetetrazole-induced seizure model.

Jarogniew J Luszczki1, Stanislaw J Czuczwar.   

Abstract

The aim of this study was to characterise the types of interactions between gabapentin (GBP), tiagabine (TGB) and three second-generation antiepileptic drugs (AEDs) with different mechanisms of action (felbamate [FBM], loreclezole [LCZ], and oxcarbazepine [OXC]) by isobolographic analysis. Anticonvulsant and acute neurotoxic adverse effect profiles of combinations of GBP and TGB with other AEDs at fixed ratios of 1:3, 1:1 and 3:1 were investigated in pentylenetetrazole (PTZ)-induced seizures and the chimney test (as a measure of motor impairment) in mice so as to identify optimal combinations. Protective indices (PIs) and benefit indices (BIs) were calculated for each combination in order to properly classify the investigated interactions. Isobolographic analysis revealed that only the combination of GBP with OXC at the fixed ratio of 1:1 exerted supra-additive (synergistic) interaction (P<0.05) against PTZ-induced seizures. The other combinations tested between GBP and OXC (1:3 and 3:1), as well as all combinations of GBP with FBM or LCZ (1:3, 1:1 and 3:1) were additive in the PTZ test. Similarly, all combinations of TGB with FBM LCZ, and OXC (at the fixed ratios of 1:3, 1:1 and 3:1) were associated with additive interactions against PTZ-induced seizures in mice. In the chimney test, the isobolographic analysis revealed that the combinations of GBP and OXC (at the fixed ratios of 1:3 and 1:1), GBP and LCZ (at 1:1), as well as TGB and OXC (at 1:3 and 1:1) were sub-additive (antagonistic; P<0.05 and P<0.01). In contrast, only one combination tested (TGB and LCZ at the fixed ratio of 1:1) was supra-additive (synergistic; P<0.05) in the chimney test, whereas the other combinations of GBP and TGB with OXC, FBM, and LCZ displayed barely additivity. Based upon the current preclinical data, GBP and OXC appear to be a particularly favourable combination. Also, the combinations of GBP with FBM, GBP with LCZ, and TGB with OXC are beneficial. In contrast, during the combining of TGB with FBM, or TGB with LCZ, the utmost caution is advised because of their unfavourable profiles in this preclinical study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133488     DOI: 10.1007/s00210-005-1088-9

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  55 in total

1.  A neuropharmacological evaluation of felbamate as a novel anticonvulsant.

Authors:  H S White; H H Wolf; E A Swinyard; G A Skeen; R D Sofia
Journal:  Epilepsia       Date:  1992 May-Jun       Impact factor: 5.864

2.  Epilepsy. Taking up GABA again.

Authors:  B Meldrum
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

3.  Synergism with GABAergic drugs in refractory epilepsy.

Authors:  J P Leach; M J Brodie
Journal:  Lancet       Date:  1994-06-25       Impact factor: 79.321

Review 4.  GABAergic mechanisms in epilepsy.

Authors:  D M Treiman
Journal:  Epilepsia       Date:  2001       Impact factor: 5.864

Review 5.  Is refractory epilepsy preventable?

Authors:  Santiago Arroyo; Martin J Brodie; Giuliano Avanzini; Christoph Baumgartner; Catherine Chiron; Olivier Dulac; Jacqueline A French; José M Serratosa
Journal:  Epilepsia       Date:  2002-04       Impact factor: 5.864

6.  Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action.

Authors:  M Schmutz; F Brugger; C Gentsch; M J McLean; H R Olpe
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

7.  Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice.

Authors:  Jarogniew J Luszczki; Mariusz Swiader; Jolanta Parada-Turska; Stanisław J Czuczwar
Journal:  Neuropsychopharmacology       Date:  2003-10       Impact factor: 7.853

8.  Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.

Authors:  Kinga K Borowicz; Mariusz Swiader; Jarogniew Luszczki; Stanislaw J Czuczwar
Journal:  Epilepsia       Date:  2002-09       Impact factor: 5.864

9.  Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor.

Authors:  E B Nielsen; P D Suzdak; K E Andersen; L J Knutsen; U Sonnewald; C Braestrup
Journal:  Eur J Pharmacol       Date:  1991-04-24       Impact factor: 4.432

10.  Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-02-19       Impact factor: 3.000

View more
  7 in total

1.  Biphasic characteristic of interactions between stiripentol and carbamazepine in the mouse maximal electroshock-induced seizure model: a three-dimensional isobolographic analysis.

Authors:  Jarogniew J Luszczki; Stanislaw J Czuczwar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-09-14       Impact factor: 3.000

2.  Influence of aminophylline on the anticonvulsive action of gabapentin in the mouse maximal electroshock seizure threshold model.

Authors:  J J Luszczki; K Jankiewicz; M Jankiewicz; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2007-08-24       Impact factor: 3.575

3.  Interactions of tiagabine with ethosuximide in the mouse pentylenetetrazole-induced seizure model: an isobolographic analysis for non-parallel dose-response relationship curves.

Authors:  Jarogniew J Luszczki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-06-20       Impact factor: 3.000

4.  Interactions between tiagabine and conventional antiepileptic drugs in the rat model of complex partial seizures.

Authors:  K K Borowicz; M Zadrozniak; J J Luszczki; S J Czuczwar
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

Review 5.  The neuropharmacology of the ketogenic diet.

Authors:  Adam L Hartman; Maciej Gasior; Eileen P G Vining; Michael A Rogawski
Journal:  Pediatr Neurol       Date:  2007-05       Impact factor: 3.372

6.  Validation of the zebrafish pentylenetetrazol seizure model: locomotor versus electrographic responses to antiepileptic drugs.

Authors:  Tatiana Afrikanova; Ann-Sophie K Serruys; Olivia E M Buenafe; Ralph Clinckers; Ilse Smolders; Peter A M de Witte; Alexander D Crawford; Camila V Esguerra
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

Review 7.  Rational Polytherapy with Antiepileptic Drugs.

Authors:  Jong Woo Lee; Barbara Dworetzky
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.